Limitations of applying summary results of clinical trials to individual patients - The need for risk stratification

被引：403

作者：

Kent, David M.

Hayward, Rodney A.

机构：

[1] Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA

[2] Univ Michigan, Vet Affairs Ann Arbor Hlth Serv Res, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Dev Serv Ctr Excellence, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 298卷 / 10期

关键词：

RANDOMIZED CONTROLLED-TRIALS; MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR; PRIMARY ANGIOPLASTY; SUBGROUP ANALYSIS; BENEFIT; HETEROGENEITY; MORTALITY; CONSUMERS; GUIDE;

D O I：

10.1001/jama.298.10.1209

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1209 / 1212

页数：4

共 22 条

[1]

The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].

Antman, EM ;

Cohen, M ;

Bernink, PJLM ;

McCabe, CH ;

Horacek, T ;

Papuchis, G ;

Mautner, B ;

Corbalan, R ;

Radley, D ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842

[2]

Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].

Assmann, SF ;

Pocock, SJ ;

Enos, LE ;

Kasten, LE .

LANCET, 2000, 355 (9209) :1064-1069

[3]

*FOOD DRUG ADM, 2001, XIGR DROTR ALF ACT P

[4]

Reporting clinical trial results to inform providers, payers, and consumers [J].

Hayward, RA ;

Kent, DM ;

Vijan, S ;

Hofer, TP .

HEALTH AFFAIRS, 2005, 24 (06) :1571-1581

[5]

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis [J].

Hayward R.A. ;

Kent D.M. ;

Vijan S. ;

Hofer T.P. .

BMC Medical Research Methodology, 6 (1)

[6]

Ioannidis JPA, 1998, AM J EPIDEMIOL, V148, P1117

[7]

The impact of high-risk patients on the results of clinical trials [J].

Ioannidis, JPA ;

Lau, J .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (10) :1089-1098

[8]

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease [J].

Kent, David M. ;

Jafar, Tazeen H. ;

Hayward, Rodney A. ;

Tighiouart, Hocine ;

Landa, Marcia ;

de Jong, Paul ;

de Zeeuw, Dick ;

Remuzzi, Giuseppe ;

Kamper, Anne-Lise ;

Levey, Andrew S. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06) :1959-1965

[9]

Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction [J].

Kent, David M. ;

Ruthazer, Robin ;

Griffith, John L. ;

Beshansky, Joni R. ;

Grines, Cindy L. ;

Aversano, Thomas ;

Concannon, Thomas W. ;

Zalenski, Robert J. ;

Selker, Harry P. .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (10) :1384-1388

[10]

Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? [J].

Kent, DM ;

Ruthazer, R ;

Selker, HP .

STROKE, 2003, 34 (02) :464-467

← 1 2 3 →